Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.92
-0.07 (-0.78%)
Mar 18, 2026, 2:57 PM EDT - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $600.92 million as of March 18, 2026. Its market cap has decreased by -9.43% in one year.
Market Cap
600.92M
Enterprise Value
860.36M
1-Year Change
-9.43%
Ranking
Category
Stock Price
$8.92
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $600.92M, a decrease of -15.77%. That is a compound annual growth rate of -3.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 605.64M | 21.54% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 734.00M |
| Integra LifeSciences Holdings | 709.23M |
| Avanos Medical | 632.91M |
| Tactile Systems Technology | 615.05M |
| Axogen | 567.87M |
| SI-BONE | 567.08M |
| Perspective Therapeutics | 563.97M |
| Cytek Biosciences | 546.34M |